New Delhi [India], January 4 (ANI): Coming down heavily on critics expressing doubts about the Bharat Biotech's indigenously developed coronavirus vaccine COVAXIN, the Hyderabad-based biotech major's managing director Dr Krishna Ella on Monday slammed the critics for targeting Indian clinica
New Delhi [India], January 4 (ANI): Union Minister for Railways Piyush Goyal on Monday said that Railways successfully conducted the first trial run of double-stack container train operation in the Western Dedicated Freight Corridor.
Hyderabad (Telangana) [India], January 4 (ANI): Covaxin, the indigenous vaccine developed by Bharat Biotech against COVID-19 in collaboration with ICMR, is 200 per cent safe, company's Chairman and Managing Director Dr Krishna Ella has said and noted that it has shown less than 10 per cen
New Delhi [India], January 4 (ANI): A day after Union Civil Aviation Minister Hardeep Singh Puri called Shashi Tharoor a cynic for criticising the Drugs Controller General of India's (DCGI) approval of COVAXIN for "restricted use in an emergency situation" without this COVID-19 vaccine havin
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
New Delhi [India], January 3 (ANI): Drugs Controller General of India (DCGI) on Sunday said the permission given to Bharat Biotech's COVAXIN is "for restricted use in an emergency situation" and it is given in "public interest as an abundant precaution" as the vaccine is still in clinical tr
Noida (Uttar Pradesh) [India], January 3 (ANI): Kumar Kundan, a journalist who volunteered for human trials of Bharat Biotech's Covid vaccine, refuted rumours about the side effects of "Covaxin" as the Drugs Controller General of India (DCGI) has finally given approval for the vaccine agains
New Delhi [India], January 3 (ANI): Hours after Drugs Controller General of India (DCGI) approved restricted use in an emergency situation to Bharat Biotech's COVID-19 vaccine, Indian Council of Medical Research (ICMR) on Sunday said data generated through pre-clinical studies and various ph
New Delhi [India], January 3 (ANI): Senior Congress leader Shashi Tharoor on Sunday said that the emergency approval to COVID-19 vaccine--Covaxin is premature and could be dangerous as it is still under phase 3 trial. He urged Union Health Minister Dr Harsh Vardhan to wait till full trials o
Hyderabad (Telangana) [India], January 2 (ANI): Bharat Biotech has recruited 23,000 volunteers so far for the Phase III clinical trials of its COVID-19 vaccine candidate, 'COVAXIN'.
New Delhi [India], January 2 (ANI): Delhi Health Minister Satyendar Jain will attend the vaccine trial program (Dry Run) conducted by the Union Health Ministry at the Maternity ND Child Welfare (MCW) centre in Daryaganj here at 10 am on Saturday.
New Delhi [India], January 1 (ANI): Union Health Minister Harsh Vardhan on Friday chaired a high-level meeting to review preparedness at session sites across the country for COVID-19 vaccination trial run on Saturday and said just like preparations during elections, each member of medical t